These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28464141)

  • 1. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing.
    Larkin I; Ang D; Steinhart J; Chao M; Patterson M; Sah S; Wu T; Schoenbaum M; Hutchins D; Brennan T; Loewenstein G
    JAMA; 2017 May; 317(17):1785-1795. PubMed ID: 28464141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restrictions on pharmaceutical detailing reduced off-label prescribing of antidepressants and antipsychotics in children.
    Larkin I; Ang D; Avorn J; Kesselheim AS
    Health Aff (Millwood); 2014 Jun; 33(6):1014-23. PubMed ID: 24889951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic prescribing: do conflict of interest policies make a difference?
    Anderson TS; Huskamp HA; Epstein AJ; Barry CL; Men A; Berndt ER; Horvitz-Lennon M; Normand SL; Donohue JM
    Med Care; 2015 Apr; 53(4):338-45. PubMed ID: 25769055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Physician-directed Pharmaceutical Promotion on Prescription Behaviors: Longitudinal Evidence.
    Datta A; Dave D
    Health Econ; 2017 Apr; 26(4):450-468. PubMed ID: 26893065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis.
    King M; Essick C; Bearman P; Ross JS
    BMJ; 2013 Jan; 346():f264. PubMed ID: 23372175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' prescribing responses to a restricted formulary: the impact of Medicaid preferred drug lists in Illinois and Louisiana.
    Virabhak S; Shinogle JA
    Am J Manag Care; 2005 Jan; 11 Spec No():SP14-20. PubMed ID: 15700905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing?
    Epstein AJ; Busch SH; Busch AB; Asch DA; Barry CL
    Med Care; 2013 Feb; 51(2):199-203. PubMed ID: 23142772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gifts and influence: Conflict of interest policies and prescribing of psychotropic medications in the United States.
    King M; Bearman PS
    Soc Sci Med; 2017 Jan; 172():153-162. PubMed ID: 27856120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician and Patient Adjustment to Reference Pricing for Drugs.
    Robinson JC; Whaley C; Brown TT; Dhruva SS
    JAMA Netw Open; 2020 Feb; 3(2):e1920544. PubMed ID: 32022881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact Of Academic Medical Center Policies Restricting Direct-To-Physician Marketing On Opioid Prescribing.
    Eisenberg MD; Stone EM; Pittell H; McGinty EE
    Health Aff (Millwood); 2020 Jun; 39(6):1002-1010. PubMed ID: 32479218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating the Strength of the Association Between Industry Payments and Prescribing Practices in Oncology.
    Mitchell AP; Winn AN; Lund JL; Dusetzina SB
    Oncologist; 2019 May; 24(5):632-639. PubMed ID: 30728276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drug sample removal on prescribing in a family practice clinic.
    Hartung DM; Evans D; Haxby DG; Kraemer DF; Andeen G; Fagnan LJ
    Ann Fam Med; 2010; 8(5):402-9. PubMed ID: 20843881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of a physician detailing and sampling program for generic atorvastatin: an interrupted time series analysis.
    Worthington HC; Cheng L; Majumdar SR; Morgan SG; Raymond CB; Soumerai SB; Law MR
    Implement Sci; 2017 Nov; 12(1):141. PubMed ID: 29178960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.
    Wood SF; Podrasky J; McMonagle MA; Raveendran J; Bysshe T; Hogenmiller A; Fugh-Berman A
    PLoS One; 2017; 12(10):e0186060. PubMed ID: 29069085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of an academic detailing intervention in primary care on the prescribing of non-steroidal anti-inflammatory drugs.
    Langaas HC; Hurley E; Dyrkorn R; Spigset O
    Eur J Clin Pharmacol; 2019 Apr; 75(4):577-586. PubMed ID: 30596208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physician Perceptions of Step Therapy Prescribing Requirements.
    Fischer MA; Kesselheim AS; Lu Z; Ross KM; Tessema FA; Avorn J
    J Manag Care Spec Pharm; 2019 Nov; 25(11):1210-1224. PubMed ID: 31663459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technology-enabled academic detailing: computer-mediated education between pharmacists and physicians for evidence-based prescribing.
    Ho K; Nguyen A; Jarvis-Selinger S; Novak Lauscher H; Cressman C; Zibrik L
    Int J Med Inform; 2013 Sep; 82(9):762-71. PubMed ID: 23770028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of conflict-of-interest policies in psychiatry residency on antidepressant prescribing.
    Epstein AJ; Asch DA; Barry CL
    LDI Issue Brief; 2013 Jan; 18(3):1-4. PubMed ID: 23610794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Industry payments and physicians prescriptions: Effect of a payment restriction policy.
    Ansari B
    Soc Sci Med; 2021 Jun; 278():113942. PubMed ID: 33892242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.